Pathogenesis and clinical approaches to anticonvulsant hypersensitivity syndrome: Current state of knowledge

International Journal of Immunopathology and Pharmacology

Volumn 24, Issue 2, 2011, Pages 277-284

  Scaparrotta, A ^a   Verrotti, A ^a   Consilvio, N P ^a   Cingolani, A ^a   Di Pillo, S ^a   Di Gioacchino, M ^a   Verini, Marcello ^a   Chiarelli, F ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

Adverse drug reaction; Anticonvulsant hypersensitivity syndrome; Antiepileptic drugs; Carbamazepine; Lamotrigine; Pathogenesis; Phenytoin

Indexed keywords

ALLOPURINOL; ANTIHISTAMINIC AGENT; ANTIRETROVIRUS AGENT; AZATHIOPRINE; BENZODIAZEPINE; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CARBAMAZEPINE; CORTICOSTEROID; DAPSONE; ETIRACETAM; FLUOXETINE; GABAPENTIN; LAMOTRIGINE; MEXILETINE; MINOCYCLINE; PHENOBARBITAL; PHENYTOIN; PREDNISOLONE; PROTON PUMP INHIBITOR; SULFONAMIDE; TERBINAFINE; TIAGABINE; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE; ANTICONVULSIVE AGENT;

AWARENESS; CLONAL VARIATION; CROSS ALLERGY; DISEASE ASSOCIATION; DRESS SYNDROME; DRUG ACTIVITY; DRUG FATALITY; FEVER; GASTROINTESTINAL HEMORRHAGE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIVER TOXICITY; MACULOPAPULAR RASH; MAJOR HISTOCOMPATIBILITY COMPLEX; MEDICAL DECISION MAKING; MULTIPLE ORGAN FAILURE; PATHOGENESIS; PRIORITY JOURNAL; RASH; REVIEW; SEIZURE; SKIN EXFOLIATION; T LYMPHOCYTE; CELL EXPANSION; CLINICAL FEATURE; AGE; DRUG HYPERSENSITIVITY; EDITORIAL; EVIDENCE BASED MEDICINE; HOSPITALIZATION; IMMUNOLOGY; MORTALITY; RISK ASSESSMENT; RISK FACTOR; SYNDROME;

AGE FACTORS; ANTICONVULSANTS; DRUG HYPERSENSITIVITY; EVIDENCE-BASED MEDICINE; HUMANS; RISK ASSESSMENT; RISK FACTORS; SEIZURES; SEVERITY OF ILLNESS INDEX; SYNDROME;

EID: 80051712018     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201102400201     Document Type: Review

References (40)

1. Franciotta D, Kwan P, Perucca E. Genetic basis for idiosyncratic reactions to antiepileptic drugs. Curr Opin Neurol 2009; 22:144-49.
2. Zaccara G, Franciotta D, Perucca E. Idiosyncratic adverse reactions to antiepileptic drugs. Epilepsia 2007; 48:1223-44. (Pubitemid 47063067)
3. Bessmertny O, Pham T. Antiepileptic hypersensitivity syndrome: clinicians beware and be aware. Curr Allergy Asthma Rep 2002; 2:34-39.
4. Elzagallaai AA, Knowles SR, Rieder MJ, et al. Patch testing for the diagnosis of anticonvulsant hypersensitivity syndrome: a systematic review. Drug Saf 2009; 32:391-408.
5. Elzagallaai AA, Knowles SR, Rieder MJ, et al. In vitro testing for the diagnosis of anticonvulsant hypersensitivity syndrome: a systematic review. Mol Diagn Ther 2009; 13:313-30.
6. Verrotti A, Trotta D, Salladini C, Chiarelli F. Anticonvulsant hypersensitivity syndrome in children. Incidence, prevention and management. CNS Drugs 2002; 16:197-205. (Pubitemid 34280603)
7. Krauss G. Current understanding of delayed anticonvulsant hypersensitivity reactions. Epilepsy Curr 2006; 6:33-37.
8. Ganeva M, Gancheva T, Lazarova R, et al. Carbamazepine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: report of four cases and brief review. Int J Dermatol 2008; 47:853-60.
9. Knowles SR, Shapiro LE, Shear NH. Anticonvulsant hypersensitivity syndrome: incidence, prevention and management. Drug Saf 1999; 21:489-501. (Pubitemid 30021105)
10. Schlienger RG, Shear NH. Antiepileptic drug hypersensitivity syndrome. Epilepsia 1998; 39:S3-7. (Pubitemid 28485581)
11. Tas S, Simonart T. Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): an update. Dermatology 2003; 206:353-56. (Pubitemid 36677029)
12. Bohan KH, Mansuri TF, Wilson NM. Anticonvulsant hypersensitivity syndrome: implications for pharmaceutical care. Pharmacotherapy 2007; 27:1425-39. (Pubitemid 47530448)
13. Schlienger RG, Knowles SR, Shear NH. Lamotrigine-associated anticonvulsant hypersensitivity syndrome. Neurology 1998; 51:1172-75. (Pubitemid 28473421)
14. Shear NH, Spielberg SP. Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. J Clin Invest 1988; 82:1826-32. (Pubitemid 19054926)
15. Haruda F. Phenytoin hypersensitivity: 38 cases. Neurology 1979; 29:1480-85. (Pubitemid 10228582)
16. Leeder JS. Mechanisms of idiosyncratic hypersensitivity reactions to antiepileptic drugs. Epilepsia 1998; 39:S8-S16. (Pubitemid 28485582)
17. Chung WH, Hung SI, Hong HS, et al. Medical genetics: a marker for Stevens-Johnson syndrome. Nature 2004; 428:86.
18. Hung SI, Chung WH, Jee SH, et al. Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions. Pharmacogenet Genomics 2006; 16:297-306.
19. Man CB, Kwan P, Baum L, et al. Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese. Epilepsia 2007; 48:1015-18. (Pubitemid 46763406)
20. Tassaneeyakul W, Tiamkao S, Jantararoungtong T, et al. Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population. Epilepsia 2010; 51:926-30.
21. Lonjou C, Thomas L, Borot N, et al. A marker for Stevens-Johnson syndrome: ethnicity matters. Pharmacogenomics J 2006; 6:265-68. (Pubitemid 44137953)
22. Kaniwa N, Saito Y, Aihara M, et al. HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis. Pharmacogenomics 2008; 9:1617-22.
23. Locharernkul C, Loplumlert J, Limotai C, et al. Carbamazepine and phenytoin-induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population. Epilepsia 2008; 49:2087-91.
24. Ikeda H, Takahashi Y, Yamazaki E, et al. HLA class I markers in Japanese patients with carbamazepine-induced cutaneous adverse reactions. Epilepsia 2010; 51:297-300.
25. Chung WH, Hung SI, Chen YT. Genetic predisposition of life-threatening antiepileptic-induced skin reactions. Expert Opin Drug Saf 2010; 9:15-21.
26. Sullivan JR, Shear NH. The drug hypersensitivity syndrome: what is the pathogenesis? Arch Dermatol 2001; 137:357-64. (Pubitemid 32240793)
27. Naisbitt DJ, Britschgi M, Wong G, et al. Hypersensitivity reactions to carbamazepine: characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clone. Mol Pharmacol 2003; 63:732-41. (Pubitemid 36297347)
28. Posadas SJ, Padial A, Torres MJ, et al. Delayed reactions to drugs show levels of perforin, granzyme B, and Fas-L to be related to disease severity. J Allergy Clin Immunol 2002; 109:155-61. (Pubitemid 34112146)
29. Chiappini E, Peruzzi M, Galli L, et al. Evidence for a T-lymphocyte dependent mechanism involving proinflammatory cytokines in anticonvulsant hypersensitivity syndrome: a case report. Int J Immunopathol Pharmacol 2002; 15:239-42. (Pubitemid 35285203)
30. Naisbitt DJ, Farrell J, Wong G, et al. Characterization of drug-specific T-cells in lamotrigine hypersensitivity. J Allergy Clin Immunol 2003; 111:1393-403. (Pubitemid 36683697)
31. Pichler WJ. Delayed drug hypersensitivity reactions. Ann Intern Med 2003; 139:683-93.
32. Naisbitt DJ, Pirmohamed M, Park BK. Immunopharmacology of hypersensitivity reactions to drugs. Curr Allergy Asthma Rep 2003; 3:22-29.
33. Kennebeck GA. Anticonvulsant hypersensitivity syndrome. J Am Board Fam Pract 2000; 13:364-70. (Pubitemid 32532298)
34. Newell BD, Moinfar M, Mancini AJ, Nopper AJ. Retrospective analysis of 32 pediatric patients with anticonvulsant hypersensitivity syndrome (ACHSS). Pediatric Dermatol 2009; 26:536-46.
35. Carroll MC, Yueng-Yue KA, Esterly NB, Drolet BA. Drug-induced hypersensitivity syndrome in pediatric patients. Pediatrics 2001; 108:485-92.
36. Bessmertny O, Hatton RC, Gonzalez-Peralta RP. Antiepileptic hypersensitivity syndrome in children. Ann Pharmacoth 2001; 35:533-38. (Pubitemid 32428125)
37. Verrotti A, Feliciani C, Morresi S, et al. Carbamazepine-induced hypersensitivity syndrome in a child with epilepsy. Int J Immunopathol Pharmacol 2000; 13:49-53. (Pubitemid 30166782)
38. Tsuge I, Okumura A, Kondo Y, et al. Allergen-specific T-cell response in patients with phenytoin hypersensitivity: simultaneous analysis of proliferation and cytokine production by carboxyfluorescein succinimidyl ester (CFSE) dilution assay. Allergol Int 2007; 56:149-55. (Pubitemid 46984243)
39. Romano A, Pettinato R, Andriolo M, et al. Hypersensitivity to aromatic anticonvulsants: in vivo and in vitro cross-reactivity studies. Curr Pharm Des 2006; 12:3373-81. (Pubitemid 44364125)
40. Aouam K, Ben Romdhane F, Loussaief C, et al. Hypersensitivity syndrome induced by anticonvulsants: possible cross-reactivity between carbamazepine and lamotrigine. J Clin Pharmacol 2009; 49:1488-91.